URGN icon

UroGen Pharma

85 hedge funds and large institutions have $137M invested in UroGen Pharma in 2023 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

25% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 20

36% less call options, than puts

Call options by funds: $193K | Put options by funds: $300K

Holders
85
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$193K
Puts
$300K
Net Calls
Net Calls Change

Top Buyers

1 +$8.42M
2 +$3.09M
3 +$1.94M
4
Northern Trust
Northern Trust
Illinois
+$1.63M
5
AA
AlphaCentric Advisors
Puerto Rico
+$1.58M

Top Sellers

1 -$4.03M
2 -$2.62M
3 -$1.93M
4
Millennium Management
Millennium Management
New York
-$1.68M
5
Bank of America
Bank of America
North Carolina
-$1.03M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$26.2M
2
$11.4M
3
$11M
4
$10.6M
5
$8.87M
6
$7.23M
7
$5.9M
8
$5.48M
9
$5.13M
10
$4.64M
11
$4.42M
12
$4.34M
13
$3.82M
14
$2.09M
15
$2.09M
16
$1.99M
17
$1.85M
18
$1.58M
19
$1.3M
20
$1.11M
21
$1.03M
22
$899K
23
$880K
24
$873K
25
$788K